iPill

In a few years, doctors won’t need to fill the bodies of gastrointestinal-cancer patients with chemotherapy drugs that also kill off normal tissue. Instead, patients will swallow an electronic pill that finds its way to a tumor, dispenses drugs onto it—and only it—and then passes harmlessly from the body. That’s the promise of the iPill, an ingestible capsule being developed by the electronics giant Philips.